Skip to Main Content

Paper Details

DNA methylation subclasses predict the benefit from gross total tumor resection in IDH-wildtype glioblastoma patients.
Neuro Oncol
18
2023
DNA, EOR, GTR, IDH-wildtype, MES, MES subclass, MES tumors, MGMT, MGMT promoter, PR, Patients, RTK, RTK I, RTK II, glioblastoma, glioblastomas, mesenchymal, patients, recurrent glioblastoma, tumor, tumors
Author NameAffiliation
Ulrich Sch??llerInstitute of Neuropathology, University Medical Center Hamburg-Eppendorf
Ulrich Sch??llerResearch Institute Children's Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf
Ulrich Sch??llerResearch Institute Children's Cancer Center Hamburg
Peter VajkoczyCharite - Universitatsmedizin Berlin
David CapperCharite - Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin and Humboldt-Universitat zu Berlin
David CapperGerman Cancer Research Center (DKFZ)
David CapperCharite - Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin and Humboldt-Universitat zu Berlin
David CapperGerman Cancer Research Center (DKFZ)
  • 1 - 8

Datasets

Release 1.2